MARK DAVIS: Open Payments
NPI 1508928714 · LAKE OSWEGO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,700 in 156 payments from 15 companies in 2025. Trend: 2023 $3,800 · 2024 $3,232 · 2025 $2,700
Food & beverage: $2,505Education: $196
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $516 |
| ABBVIE INC. | 22 | $386 |
| Novartis Pharmaceuticals Corporation | 28 | $374 |
| Arcutis Biotherapeutics, Inc. | 20 | $274 |
| Regeneron Healthcare Solutions, Inc. | 7 | $244 |
| Lilly USA, LLC | 15 | $170 |
| PFIZER INC. | 7 | $145 |
| UCB, Inc. | 11 | $145 |
| Mallinckrodt Hospital Products Inc. | 3 | $105 |
| Organon LLC | 3 | $76 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Zoryve, COSENTYX, TALTZ, CIBINQO, Bimzelx.
Industry payments across OR — which companies pay providers there.
